1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Aortic Diseases in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Aortic Diseases: Pathological processes involving any part of the AORTA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Noma, K | 1 |
Goto, C | 1 |
Nishioka, K | 1 |
Jitsuiki, D | 1 |
Umemura, T | 1 |
Ueda, K | 1 |
Kimura, M | 1 |
Nakagawa, K | 1 |
Oshima, T | 1 |
Chayama, K | 1 |
Yoshizumi, M | 1 |
Liao, JK | 1 |
Higashi, Y | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Aortic Diseases
Article | Year |
---|---|
Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Adult; Aortic Diseases; Atherosclerosi | 2007 |